Stifel Financial
ETTX

Stifel Financial’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Stifel Financial’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-21,250
Closed -$86K – 2880
2018
Q4 		$86K Sell
21,250
-8,750
-29% -$57.6K ﹤0.01% 2578
2018
Q3 		$326K Buy
+30,000
New +$315K ﹤0.01% 2318

Other funds holding ETTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stifel Financial's ETTX Position: Q1 2019 in Review

Stifel Financial sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2019, closing a stake of 21,250 shares — an estimated $86K sold.

Stifel Financial first reported a position in ETTX in Q3 2018 and held it in 2 quarters. The position peaked at $326K in Q3 2018. 17 funds tracked by Wall St. Rank hold ETTX as of Q1 2019.

  • Stifel Financial reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2019 after selling out during the quarter.
  • Stifel Financial sold 21,250 Entasis Therapeutics Holdings Inc. shares in Q1 2019, an estimated $86K.
  • Stifel Financial first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2018 and held it in 2 quarters.
  • Stifel Financial's Entasis Therapeutics Holdings Inc. position peaked at $326K in Q3 2018.
  • 17 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2019.

Based on Stifel Financial's 13F filing for Q1 2019, filed 14 May 2019.